Clinical trial
Asacol Dosing Study for Active Ulcerative Colitis
NCT00194818 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00194818 |
|---|---|
| Title | Asacol Dosing Study for Active Ulcerative Colitis |
| Official title | Open Label Safety and Efficacy Trial of Twice Daily Dosing of Asacol vs. Three Times Per Day Dosing for the Induction of Remission in Active Ulcerative Colitis |
| Lead sponsor | University of Washington, Other |
| Collaborators | Procter and Gamble Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Ulcerative Colitis |
| Intervention type | Drug |
| Interventions | Asacol (mesalamine) |
| Enrollment | 7 |
| Start date | Jun 1, 2003 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Sep 19, 2005 |
| Last update posted | Feb 15, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: